New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 20, 2014
07:56 EDTDTV, JPM, AZN, T, LAZ, PFE, BACLazard shares rise after AT&T mega-deal struck, WSJ says
Shares of Lazard (LAZ) rose yesterday after AT&T (T), which Lazard was the advisor for, announced its deal to acquire DirecTV (DTV), reported The Wall Street Journal. In contrast, JPMorgan (JPM), Bank of America (BAC) and Guggenheim Partners look set to be disappointed and lose out on potential fees as Pfizer's (PFE) bid for AstraZeneca (AZN) appears destined to fail, the report noted. The Journal added that the total value of agreed-upon U.S. deals is up 87% from last year to $585B year-to-date. Reference Link
News For LAZ;JPM;BAC;T;DTV;PFE;AZN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
May 12, 2015
11:14 EDTT, DTVAOL premium low but likely best bet for AOL shareholders, Bloomberg says
Subscribe for More Information
10:32 EDTTAcacia Research enters settlement, license agreement with AT&T Mobility
Subscribe for More Information
08:31 EDTDTVApple likely to launch TV video service this year, says Pacific Crest
Subscribe for More Information
May 11, 2015
17:36 EDTPFEAthersys down 10.1% after Pfizer notified that it will terminate agreement
Subscribe for More Information
17:34 EDTPFEAthersys receives notification that Pfizer will terminate agreement
Subscribe for More Information
16:33 EDTPFEPfizer takes minority interest in AM-Pharma, secures option to acquire company
AM-Pharma and Pfizer announced that Pfizer has acquired a minority equity interest in AM-Pharma and secured an exclusive option to acquire the remaining equity in the company. The option becomes exercisable upon completion of a Phase II trial of recAP in the treatment of Acute Kidney Injury related to sepsis. There are no drugs currently approved for this condition and the only treatment option is dialysis and supportive care. Results from the current Phase II trial for recAP are expected in the second half of 2016. Under the terms of the agreement, Pfizer has made an upfront payment of $87.5M for the minority equity interest and exclusive option, with additional potential payments of up to $512.5M upon option exercise and potential launch of any product that may result from this agreement. Other terms of the transaction were not disclosed. “Pfizer is committed to advancing the science to address the high unmet medical need in Acute Kidney Injury,” said Mikael Dolsten, M.D., Ph.D., president, Worldwide Research and Development at Pfizer. “Clinical data for recAP show the potential to uniquely address Acute Kidney Injury in the setting of sepsis, and we look forward to working with our partners at AM-Pharma as we aim to accelerate the development of recAP into a potential first-in-class treatment for patients.”
16:00 EDTBACOptions Update; May 11, 2015
Subscribe for More Information
12:06 EDTTAT&T appoints Jeffrey Lewis Chief Accessibility Officer
Subscribe for More Information
09:59 EDTJPMOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:58 EDTBAC, JPMBarclays expected to pay GBP2B to settle forex rigging charges, FT says
Subscribe for More Information
09:37 EDTBACActive equity options trading on open
Subscribe for More Information
08:18 EDTBAC, JPMBanks executives seek to push back on 'false, damaging' statements, WSJ reports
Subscribe for More Information
07:46 EDTJPMJPMorgan price traget raised to $73 from $68 at BofA/Merrill
BofA/Merrill raised Buy rated JPMorgan's price target to $73 following a meeting with Chairman Jamie Dimon. The analyst believes earnings surprises are likely and the market is over-discounting the impact of regulation. BofA/Merrill expects JPMorgan to benefit from its multi-dimensional model, EPS sensitivity to rising interest rates, and a shift in Fed monetary policy which will drive bond market volatility.
07:28 EDTJPMJPMorgan downgraded to Neutral from Buy at MKM Partners
Subscribe for More Information
May 10, 2015
20:03 EDTJPMCiti, JPMorgan, UBS consider exiting U.K., Financial Times says
Citi (C), JPMorgan (JPM), and UBS (UBS) are considering exiting their London operations due to the U.K.'s bank levy, reports the Financial Times, citing people familiar with the matter. There is particular focus among the banks to reduce repurchase agreements, said three senior industry figures. The Financial Times notes that the recent Conservative win could see political maneuvers to reduce or renegotiate the levy, potentially persuading the banks to stay. Reference Link
18:05 EDTT, DTVFCC contract ruling may speed review of AT&T-DirecTV merger, WSJ says
Subscribe for More Information
May 8, 2015
16:05 EDTBACOptions Update; May 8, 2015
Subscribe for More Information
09:36 EDTBACActive equity options trading on open:
Active equity options trading on open: AAPL BABA FB DIS MSFT TSLA NFLX AMZN BAC
06:48 EDTBAC, JPMBanks to erase debt of bankrupt consumers from reports, NY Times says
Subscribe for More Information
06:35 EDTBACShareholder support for Bank of America board drops, Reuters says
None of the four Bank of America directors up for reelection this week received more than 71.9% of votes, according to Reuters. Last year, none of the directors received less than 98% of votes, the news service stated. Reference Link
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use